Literature DB >> 1436453

Volume measurement of multiple sclerosis lesions with magnetic resonance images. A preliminary study.

D A Wicks1, P S Tofts, D H Miller, G H du Boulay, A Feinstein, R P Sacares, I Harvey, R Brenner, W I McDonald.   

Abstract

The ability to visualise multiple sclerosis lesions in vivo with magnetic resonance imaging suggests an important role in monitoring the course of the disease. In order to help the long-term assessment of prospective treatments, a semi-automated technique for measuring lesion volume has been developed to provide a quantitative index of disease progression. Results are presented from a preliminary study with a single patient and compared to measurements taken from lesion outlines traced by a neuroradiologist, two neurologists and a technician. The semi-automated technique achieved a precision of 6% compared to a range of 12-33% for the manual tracing method. It also reduced the human interaction time from at least 60 min to 15 min.

Entities:  

Mesh:

Year:  1992        PMID: 1436453     DOI: 10.1007/bf00598953

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

2.  Three-dimensional segmentation of MR images of the head using probability and connectivity.

Authors:  H E Cline; W E Lorensen; R Kikinis; F Jolesz
Journal:  J Comput Assist Tomogr       Date:  1990 Nov-Dec       Impact factor: 1.826

3.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Authors:  D H Miller; F Barkhof; I Berry; L Kappos; G Scotti; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

4.  Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

Authors:  J H Noseworthy; M K Vandervoort; C J Wong; G C Ebers
Journal:  Neurology       Date:  1990-06       Impact factor: 9.910

5.  Segmentation of MR brain images into cerebrospinal fluid spaces, white and gray matter.

Authors:  K O Lim; A Pfefferbaum
Journal:  J Comput Assist Tomogr       Date:  1989 Jul-Aug       Impact factor: 1.826

6.  In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis.

Authors:  H B Larsson; J Frederiksen; L Kjaer; O Henriksen; J Olesen
Journal:  Magn Reson Med       Date:  1988-05       Impact factor: 4.668

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  Nuclear magnetic resonance imaging of the brain in multiple sclerosis.

Authors:  I R Young; A S Hall; C A Pallis; N J Legg; G M Bydder; R E Steiner
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

9.  Multiple sclerosis: a serial study using MRI in relapsing patients.

Authors:  C Isaac; D K Li; M Genton; C Jardine; E Grochowski; M Palmer; L F Kastrukoff; J Oger; D W Paty
Journal:  Neurology       Date:  1988-10       Impact factor: 9.910

10.  The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.

Authors:  I E Ormerod; D H Miller; W I McDonald; E P du Boulay; P Rudge; B E Kendall; I F Moseley; G Johnson; P S Tofts; A M Halliday
Journal:  Brain       Date:  1987-12       Impact factor: 13.501

View more
  16 in total

1.  Supervised automatic procedure to identify new lesions in brain MR longitudinal studies of patients with multiple sclerosis.

Authors:  R C Parodi; F Levrero; M P Sormani; A Pilot; G L Mancardi; A Aliprandi; F Sardanelli
Journal:  Radiol Med       Date:  2008-04-02       Impact factor: 3.469

2.  Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques.

Authors:  P D Molyneux; P S Tofts; A Fletcher; B Gunn; P Robinson; H Gallagher; I F Moseley; G J Barker; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

Review 3.  Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment.

Authors:  M Filippi; M Rovaris; G Comi
Journal:  Ital J Neurol Sci       Date:  1996-12

4.  Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.

Authors:  M Filippi; R Capra; A Campi; B Colombo; F Prandini; N Marcianò; R Gasparotti; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

5.  Does hemispheric dominance influence brain lesion distribution in multiple sclerosis?

Authors:  M Filippi; G Martino; S Mammi; A Campi; G Comi; L M Grimaldi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

6.  Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.

Authors:  T Koudriavtseva; A J Thompson; M Fiorelli; C Gasperini; S Bastianello; A Bozzao; A Paolillo; A Pisani; S Galgani; C Pozzilli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

Review 7.  Magnetic resonance imaging in degenerative ataxic disorders.

Authors:  I E Ormerod; A E Harding; D H Miller; G Johnson; D MacManus; E P du Boulay; B E Kendall; I F Moseley; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

8.  Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study.

Authors:  M Filippi; G J Barker; M A Horsfield; P R Sacares; D G MacManus; A J Thompson; P S Tofts; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

9.  Database for serial magnetic resonance imaging in multiple sclerosis.

Authors:  F Barkhof; A J Thompson; L Kappos; J J Nauta; T Yousri; I Berry; G Scotti; B Appel; P S Tofts; D H Miller
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

10.  Serial gadolinium-enhanced magnetic resonance imaging in patients with multiple sclerosis treated with mitoxantrone.

Authors:  H Krapf; E Mauch; U Fetzer; H Laufen; H H Kornhuber
Journal:  Neuroradiology       Date:  1995-02       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.